Usefulness and difficulties with the thiopurine pharmacogenomic NUDT15 genotyping test: Analysis of real-world data in Japan
The usefulness of NUDT15 genotyping as a pharmacogenomic test for thiopurine has been established. The first such test developed to date, NUDT15 genotyping was approved for reimbursement in Japan in February 2019 for all indicated patients. We retrospectively examined claims data in Japan and confir...
Main Authors: | Yoichi Kakuta, Motohiro Kato, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Masatake Kuroha, Hisashi Shiga, Yoshitaka Kinouchi, Atsushi Masamune |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861323000555 |
Similar Items
-
Importance of <i>NUDT15</i> Polymorphisms in Thiopurine Treatments
by: Yoichi Tanaka, et al.
Published: (2021-08-01) -
A direct sequencing assay for pharmacogenetic testing of thiopurine-intolerant NUDT15 alleles in an Asian population
by: Kok-Siong Poon, et al.
Published: (2022-04-01) -
TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
by: Liuh Ling Goh, et al.
Published: (2022-09-01) -
gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
by: Katsuyoshi Matsuoka
Published: (2020-07-01) -
NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
by: Toshiyuki Sato, et al.
Published: (2017-07-01)